Why Avenex
Avenex is a founder-first biotech incubator. Our senior advisors—15–20-year veterans across new drug discovery, clinical development, regulatory, commercialization, and BD—act as embedded operators to shape IND/CTA paths (China/global), design and run pragmatic studies, translate biology to milestones, and craft narratives that pass diligence.
For Avenex‑backed projects, founders receive free access to our AI stack—drug discovery tools, real‑time business intelligence, and clinical research data management suites—to move from concept to fundable milestones faster and with rigor.
The Classics
Business Intelligence LLM
A next-generation Large Language Model (LLM) purpose-built for biotech and pharmaceutical industries.
It ingests vast datasets—including clinical readouts, regulatory filings, competitive landscapes, and investor commentary—and translates them into decision-ready insights.
Specialty:
-
Real-Time Sentiment and Risk Analysis: Tracks news and social streams for emerging trends and risks.
-
Auto-Built Competitive Maps: Provides comprehensive competitive intelligence, including target-indication maps.
-
Custom Query and Retrieval: Offers cited, exportable reports with user-tailored insights.
Technical Differentiation: -
Lightweight fine-tuning ensures outputs remain current, explainable, and actionable.
-
Seamlessly integrates private datasets while keeping your data secure and confidential.
Bio-Designer
AI- drug discovery agent
An advanced AI-powered Automated Intelligent Drug Discovery (AIDD) Agent designed to accelerate drug discovery workflows.
This platform prioritizes targets, designs and optimizes candidates, and predicts properties for multi-modal molecules (e.g., mRNA, siRNA, small molecules, peptides).
Specialty:
-
Disease-Centric Discovery: Uses disease-network analytics to rank hypotheses and accelerate target identification.
-
Predictive Modeling: Integrates ADME/T (absorption, distribution, metabolism, excretion/toxicity) and developability predictions.
-
Virtual Pharmacology: Simulates pharmacology and toxicology, enabling faster preclinical evaluation.
Technical Differentiation: -
Combines RNA analytics, de novo molecule generation, and cohort enrichment for precision targeting.
-
Delivers earlier, evidence-based go/no-go decisions to optimize timelines and reduce risk.
ClinCore
Clinical Research Management Suite
A cloud-native Electronic Data Capture (EDC) system tailored for clinical research data management.
Simplifies clinical trial operations, from study design to data lock, with robust compliance and real-time insights.
Specialty:
-
Unified Patient and Study Data: Integrates eCRF/EDC, CTMS, eConsent, and analytics into a single platform.
-
Regulatory-Ready: Built to meet international standards (e.g., CDISC, ICH-MedDRA, CFR Part 11).
-
Risk-Based Monitoring: Features multi-center permissions, audit trails, and encrypted transmissions.
Technical Differentiation: -
Enables seamless export to SPSS/SAS/Excel for advanced analytics.
-
Provides mobile/web access for real-time updates and automated follow-ups, maintaining audit-ready integrity.